Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | AXL CAR-T cells |
| Synonyms | |
| Therapy Description |
AXL CAR-T cells are T-cells that are modified to express a chimeric antigen receptor recognizing AXL, which may result in increased death of AXL-expressing tumor cells upon infusion (PMID: 29497107). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| AXL CAR-T cells | AXL CAR-T cells are T-cells that are modified to express a chimeric antigen receptor recognizing AXL, which may result in increased death of AXL-expressing tumor cells upon infusion (PMID: 29497107). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| AXL positive | chronic myeloid leukemia | sensitive | AXL CAR-T cells | Preclinical - Cell culture | Actionable | In a preclinical study, treatment with AXL CAR-T cells led to induced death of AXL-expressing chronic myeloid leukemia (CML) cells and did not induce death of AXL-negative CML cells in culture (PMID: 29497107). | 29497107 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|